Product Information
OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0810 per EA under NDC 43547030009. Its NADAC has been published 151 times since Oct 4, 2023.
FDA first approved this application on Dec 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547030009
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206720FDA Approved
12/2/2022
TE Code
AB
On Market Since
3/4/2022
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 151 times since Oct 4, 2023, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0810 per EA |
|---|---|
| All-time high | $0.0925 (Apr 10, 2024) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0825 |
| 52-week low | $0.0732 |
| Median price | $0.0814 |
| Average price | $0.0808 |
| Largest weekly change | -20.3% (Nov 20, 2024) |
| Weeks tracked | 151 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0810 per EA (NDC 43547030009), effective Aug 19, 2026.
How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 6.1%. It has been tracked across 151 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?
Since Oct 4, 2023, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $0.0925 (Apr 10, 2024), with a median of $0.0814 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 20 MG TAB, is $0.0780 per EA — about 4% below OLMESARTAN MEDOXOMIL 20 MG TAB.
Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?
OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 43547030009) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.